Follow-The-Filings

Security · featured owners

INBX Inhibrx Biosciences Inc.

COM Equity as of 2026 Q2 among managers we track

  • 3 Owners
  • Max 0.5%
  • $110M
  • 2 new 1 reduce

Who owns this now

Largest portfolio weights among featured holders · max 0.5% (Nehal Chopra - Ratan Capi...) · not free-float ownership

  1. Nehal Chopra new 0.51%
  2. Andreas Halvorsen reduce 0.30%
  3. James Silverman new 0.17%

holders

sorted by value · long equity only · current book 2026 Q2 · open a manager for their book

history
Andreas Halvorsen - Viking Global Investors 2026 Q2 0.30% Reduce −21.8% 1,123,929 $106M history
James Silverman - Opaleye Management 2026 Q2 0.17% New 0.17% 20,291 $2M history
Nehal Chopra - Ratan Capital Management 2026 Q2 0.51% New 0.51% 16,612 $2M history

3 current · options excluded

SEC filings

Recent issuer filings from EDGAR · 25 shown · open Filing / Doc on SEC.gov

Filed Form Detail Links
10-Q 10-Q Filing Doc
8-K 2.02,9.01 Filing Doc
8-K 1.01,2.03,3.02,7.01,9.01 Filing Doc
8-K 7.01,8.01,9.01 Filing Doc
8-K 5.07 Filing Doc
10-Q 10-Q Filing Doc
8-K 2.02,9.01 Filing Doc
8-K 7.01,8.01,9.01 Filing Doc
DEFA14A DEFA14A Filing Doc
8-K 7.01,8.01,9.01 Filing Doc
10-K 10-K Filing Doc
8-K 2.02,9.01 Filing Doc
8-K 7.01,9.01 Filing Doc
8-K 7.01,8.01,9.01 Filing Doc
10-Q 10-Q Filing Doc
8-K 2.02,9.01 Filing Doc
8-K 7.01,8.01,9.01 Filing Doc
10-Q 10-Q Filing Doc
8-K 2.02,9.01 Filing Doc
8-K 5.07 Filing Doc
424B3 424B3 Filing Doc
10-Q 10-Q Filing Doc
8-K 2.02,9.01 Filing Doc
424B3 424B3 Filing Doc
DEFA14A DEFA14A Filing Doc

Insider forms

Form 3 / 4 / 5 from EDGAR · 13 shown

Filed Form Detail Links
4 Period Jun 3, 2026 · 4 forms Filing Doc
4 Period Apr 24, 2026 Filing Doc
4 Period Oct 7, 2025 Filing Doc
4 Period May 28, 2025 · 4 forms Filing Doc
4 Period Apr 1, 2025 · 2 forms Filing Doc
4 Period Mar 27, 2025 Filing Doc

Updated 7 days ago Source: SEC EDGAR submissions All on EDGAR

financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2024 FY2025
Revenue $200,000 $1.3M
Net income $1.69B -$140.06M
Net margin * 843786.0% -10773.5%

Balance sheet

Metric FY2024 FY2025
Total current assets $160.4M $132.83M
Total non-current assets * $20.37M $13.65M
Total assets $180.77M $146.48M
Total current liabilities $40.73M $33.8M
Total non-current liabilities * $6.45M $104.69M
Total equity $133.58M $7.99M

Cash flow

Metric FY2024 FY2025
Cash from operations -$194.41M -$129.79M
Cash from investing -$2.6M -$28,000
Cash from financing $71.68M $101.45M
Net change in cash -$125.33M -$28.38M

Source: SEC companyfacts (US-GAAP 10-K) · * = computed (not a single XBRL tag) · fiscal year as labeled by the issuer · not adjusted or audited by Follow-The-Filings

ownership over time

filing count by report period · click a bar for that quarter’s holders